Cited by 75Pituitary Gland Disorders and TreatmentsGrowth Hormone and Insulin-like Growth FactorsBone health and osteoporosis research

Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine

Kayath, M. J., Vieira, J. G. H.·1997·Osteoporosis International

Abstract

Acromegaly may induce abnormalities in bone metabolism; however, there are limited data related to bone mineral density (BMD) in this condition. To evaluate the effects of an excess of growth hormone/ insulin-like growth fractor I (GH/IGF-I) in the skeleton, we measured the BMD in spine and femoral region, total body calcium and body composition in 45 patients (24 females and 21 males) aged 21-77 years (median 43 years) with acromegaly for 11.4 +/- 7.5 years (range 0.5-26 years) using a dual-energy X-ray absorptiometer (Lunar DPX). Thirty-four patients had had hypogonadism for 8.6 +/- 6.5 years (1-24 years). Mean serum GH and IGF-I levels were respectively 159 +/- 183 micrograms/l and 843 +/- 497 micrograms/l. Total body calcium was increased in the acromegalics (males: 1272 +/- 217 g, range 916-1816 g; females: 1041 +/- 223 g, range 739-1609 g) when compared with normal individuals (males: 1115 +/- 144 g, range 856-1398 g; females: 909 +/- 144 g, range 511-1311 g; p = 0.01). The lean body mass was significantly higher in acromegalic patients (p < 0.001) compared with normal individuals. There was a tendency for a lower fat percentage in the acromegalics; however, this difference was not significant. Osteopenia (1 Z-score below the mean) was found in the spine in 20% (n = 9) of the patients, while BMD was decreased in the femoral region in only 8.8% (n = 4). The group with osteopenia had a greater duration of hypogonadism than the normal BMD group (14 +/- 11 years vs 4.4 +/-…

Integrity signals

Registry

Crossref · 10.1007/bf01622293

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hypogonadal patients with acromegaly are at higher risk of osteoporosis, particularly at sites composed predominantly of trabecular bone.

    “Hypogonadal patients with acromegaly are at higher risk of osteoporosis, particularly at sites composed predominantly of trabecular bone, which has more intimate contact with the circulation and is influenced by sex steroids to a greater extent [34, 39, 40].”

    From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [34]

  • Information about the influence of GH excess on BMD varies in the literature: in some studies BMD was increased or within reference ranges, while in other papers it was decreased.

    “Information about the influence of GH excess on BMD varies in the literature. In some studies BMD was reported to be increased or within the reference ranges, while in other papers it was decreased [17, 26, 34–37].”

    From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [34]

  • Impaired gonadal status including hypogonadism and hyperprolactinemia is thought to be a cause of BMD decline in acromegaly.

    “Impaired gonadal status including hypogonadism and hyperprolactinemia is thought to be a cause of BMD decline [28, 34].”

    From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [34]

  • Serum calcium and phosphate values and 24-hour urinary calcium are elevated in patients with active acromegaly.

    “Additionally, serum calcium and phosphate values and 24-hour urinary calcium are elevated in patients with active disease [27, 29, 34, 35, 41].”

    From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [34]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kayath, M. J., & Vieira, J. G. H.
Affiliations
Universidade Federal de São Paulo (BR)
Venue
Osteoporosis International
Published
1997-05
Volume
7
Issue
3
Pages
226-230
ISSN
  • 0937-941X (ISSN-L)
  • 1433-2965
OpenAlex
W2027471596
Cited by
75
References
1
Citations by year
2024: 2 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 3 · 2019: 3 · 2018: 7 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 6 · 2013: 2 · 2012: 2
FWCI
0.71
Type
journal article
Language
en
Open access
closed
Locations
  • Osteoporosis International (publishedVersion)
  • PubMed (publishedVersion)
  • UNIFESP Institutional Repository (Universidade Federal de São Paulo) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
acromegaly, osteopenia, bone mineral density, spine, femoral bone density, hypogonadism, growth hormone excess, insulin-like growth factor I, bone metabolism, body composition, total body calcium, lean body mass, osteoporosis risk factors, sex differences, age differences, body weight
MeSH terms
Acromegaly, Adult, Aged, Body Composition, Bone Diseases, Metabolic, Calcium, Female, Humans, Hypogonadism, Insulin-Like Growth Factor I, Male, Middle Aged, Growth Hormone, Spinal Diseases, Time Factors, Absorptiometry, Photon, Bone Density, Body Mass Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review